|2014 iBIO IndEx Agenda - April 24|
7:00 – 8:00 AM
Welcome8:00 – 8:15 AM
Morning Keynote8:15 – 9:00 AM
John J. Castellani, President, Pharmaceutical Research and Manufacturers of America
Panel Session9:00 – 10:30 AM
Innovative Data Use to Drive Clinical Trial Optimization and Treatment
Patient data is being used in new and innovative ways to optimize clinical trials and treatments. Through integration of patient’s clinical data, tissue, and molecular data, it provides the ability to discover new biomarkers and drug targets, enhanced ability to match patient to right treatment or clinical trials, superior data for clinical decision-making, and improved ability to track and understand patient treatments, outcomes and costs. Deloitte is a leader in helping companies innovate and implement solutions, using data to maximize clinical trial outcomes and patient treatments. This session will review what is happening today and is poised to happen in the future through innovative use of data.
Coffee Break10:30 – 11:00 AM
11:00 AM – 12:00 PM
These industry giants will provide their exclusive insights in an intimate, interactive environment. Speakers will discuss the most crucial issues facing the industry, drawing from personal observations and experiences across their fields. Attendees can expect to gain a deep understanding of the industry’s most pressing challenges and opportunities. Audience questions and dialogues are encouraged.
12:00 – 1:30 PM
International panel "The World is Flat:Illinois' links to global lifesceince clusters and markets"
12:00 – 1:30 PM
1:30 – 3:00 PM
How the Biotech Boom is Changing Deal Structures
The JOBS Act
and changes in the regulatory environment have led to a number of positive
changes for the life sciences community. The trend of initial public offerings
has led to a recent biotech boom and renewed faith in investors. With the
increased number of companies hitting the public market and continued pipeline
issues for the existing large companies, how is this driving changes in the
deal structure? This panel will review the recent biotech boom and take a
forward look at how this trend will continue. It will review how a shifting
regulatory environment with the FDA is helping to fuel the trend and how the
large companies are going to benefit.
3:00 – 3:30 PM
3:30 – 4:30 PM
This panel will provide their insights in an intimate, interactive environment. Speakers will discuss the challenges facing the startup industry in Illinois, drawing from personal observations and experiences. Attendees can expect to gain a deep understanding of the industry’s most pressing challenges and opportunities. Audience questions and dialogues are encouraged.
TO REGISTER, VISIT IBIO.ORG/2014INDEXREGISTRATION.